KATHERINE WILSON: Open Payments
NPI 1235353988 · ST. JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 33 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $335 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $151 |
| Novo Nordisk Inc | 10 | $144 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Wegovy, REXULTI, VRAYLAR, QULIPTA, Ozempic, SHINGRIX, UBRELVY, OTEZLA.
Industry payments across FL — which companies pay providers there.
